Drug Shortage Report for PAMIDRONATE DISODIUM FOR INJECTION
| Report ID | 181148 |
| Drug Identification Number | 02246599 |
| Brand name | PAMIDRONATE DISODIUM FOR INJECTION |
| Common or Proper name | PAMIDRONATE DISODIUM FOR INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | PAMIDRONATE DISODIUM |
| Strength(s) | 9MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10mL |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-01-09 |
| Estimated end date | 2023-03-31 |
| Actual end date | 2023-03-31 |
| Shortage status | Resolved |
| Updated date | 2023-04-03 |
| Company comments | Product is on 100% allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-04-03 | French | Compare |
| v3 | 2023-04-03 | English | Compare |
| v2 | 2023-01-16 | French | Compare |
| v1 | 2023-01-16 | English | Compare |
Showing 1 to 4 of 4